Homologous Recombination Deficiency (HRD) Testing in Ovarian Cancer

イルミナゲノミクスポッドキャスト

Homologous Recombination Deficiency (HRD) Testing in Ovarian Cancer

Nov 11, 2022 | Episode 76 | 6 mins

Isabelle Ray-Coquard, MD, PhD, explains how comprehensive genomic profiling (CGP) simultaneously provides HRD and BRCA status in ovarian cancer patients. She presents the case of a patient who benefited from CGP testing for these biomarkers and shares the recent findings of the PAOLA-1 trial.

Download or subscribe to our recurring podcasts.